Comments
Amid meningitis crisis, critics say Medicare may promote risky drug compounding
20.11.2012. | NEW YORK (Reuters) - With 34 deaths and 474 cases of fungal meningitis linked to tainted steroids from a Massachusetts compounding pharmacy, blame has fallen on everyone from the pharmacy to state and federal regulators. Now a new potential culprit has emerged: Medicare, which reimburses for almost all compounded drugs....
